在家庭运动期间为患有慢性阻塞性肺病的患者提供移动应用程序:可用性研究
Shih-Ying Chien1,2,3
1Department of Industrial Design, Chang Gung University, Taoyuan, Taiwan.
JMIR human factors
|November 15, 2024
概括
这项研究评估了一款用于慢性阻塞性肺病家庭监测的移动应用程序. 虽然医疗保健专业人员发现它很容易使用,但患者遇到了导航挑战,强调需要以用户为中心的设计改进,以实现更广泛的采用.
科学领域:
- 数字健康数字健康
- 医疗信息学 医疗信息学
- 人与计算机的互动.
背景情况:
- 数字健康工具对慢性疾病管理和减少医疗保健专业人员工作负担充满希望.
- 早期用户体验分析往往缺乏数字健康工具开发,导致采用率低.
研究的目的:
- 评估一个移动应用程序的可用性和满意度,用于在家对慢性阻塞性肺病 (COPD) 患者的临床监测.
主要方法:
- 12名医疗保健专业人员和18名COPD患者使用混合方法方法.
- 可用性测试涉及模拟审查和任务完成,使用NVivo12.0.0分析数据.
- 任务难度和满意度使用评级表进行了测量.
主要成果:
- 与患者 (22%) 相比,医疗保健专业人员报告了更高的易用性 (66%).
- 没有出现关键错误,两组的整体满意度都很高.
- 老年人和非母语使用者面临着特定的可用性挑战,这表明需要适应性设计功能.
结论:
- 虽然医疗人员发现该应用程序是直观的,但患者报告了导航和连接方面的困难.
- 建议对设计进行改进,例如基于图标的进度指标和听力支持,以实现公平访问.
- 尽管面临挑战,但该应用程序表现出高度满意度,并有可能在以代设计改进为基础的家庭COPD护理中增加使用.
相关概念视频
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.6K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182